Compare HCA Health Inc (HCA) vs Nutanix Inc (NTNX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Nutanix Inc — how do they compare? HCA Health Inc trades at $410.61 (market cap $89.08B), while Nutanix Inc trades at $63.92 (market cap $17.39B). The key difference: HCA Health Inc is far larger — about 5.1× Nutanix Inc's market cap, and HCA Health Inc pays a 0.76% dividend while Nutanix Inc pays none. Which is the better fit depends on your goals.
| HCA | NTNX | |
|---|---|---|
Market Cap | $89.08B | $17.39B |
Sector | Health | Technology |
52-Week High | $545.13 | $81.12 |
52-Week Low | $361.32 | $34.41 |
Enterprise Value | $139.62B | $16.90B |
Dividend Yield | 0.76% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $414.03, up 0.16% today, with strong technical momentum as price sits above key support levels. The company demonstrates solid fundamentals with Q2 2026 earnings beating estimates, revenue growth to $75.6B in 2025, and consistent dividend payments. Recent management appointments signal strategic focus on clinical operations and ambulatory services.
HCA presents a compelling investment case with attractive valuation (P/E 13.8), analyst consensus price target of $449.93 (8.7% upside), and strong institutional support. However, risks include ongoing legal investigations, rising expenses impacting margins, and high debt levels at 80.9% debt-to-asset ratio that could constrain financial flexibility.
Nutanix (NTNX) trades at $63.74, down 1.12% today, showing strong fundamental momentum with consistent earnings beats and robust revenue growth. The stock maintains a bullish technical outlook with moving averages supporting upward momentum, though RSI levels suggest potential overbought conditions. Recent institutional buying activity and positive analyst sentiment (62.5% buy ratings) reflect confidence in the hybrid multicloud platform's growth trajectory.
Outlook remains positive with Q4 earnings expected to beat consensus, though supply chain constraints pose near-term risks. The company's expanding profit margins and VMware migration opportunities provide upside potential, but elevated valuation metrics (P/E 67.71) require continued execution. Investors should monitor Q2 2026 earnings results due August 26th for confirmation of growth sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Nutanix Inc
Nutanix, Inc. is a global leader in cloud software and hyperconverged infrastructure (HCI) solutions. The company's platform converges computing, virtualization, and storage into a single, seamless software-defined solution, enabling private, hybrid, and multi-cloud environments. Nutanix helps organizations simplify data center operations, manage their applications across various cloud platforms, and reduce IT complexity, positioning it as a key enabler of modern hybrid cloud strategies.
Read more on NTNX →
